Tectonic Therapeutic, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 19.56 USD (Oct 30, 2026, 1:42 PM EDT) · Market cap 382.39M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
Details
| Name | Tectonic Therapeutic, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 60 |
| Founded | 2019 |
| Ipo Date | 2018-06-21 |
| Ceo | Alise Reicin |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US8789721086 |
| Cusip | 878972108 |
| Cik | 1681087 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Alise S. Reicin M.D., Ph.D. | President, Chief Executive Officer, Secretary and Director |
| Daniel Lochner M.B.A. | Chief Financial Officer |
| Dr. Marcella Kuhlman Ruddy M.D., M.S. | Chief Medical Officer |
| Washington Alves M.S. | Senior Vice President of Technical Operations |
| Dr. Peter McNamara Ph.D. | Chief Scientific Officer |
| Geraldine Peters-Wiles | Senior Vice President of Human Resources |
| Anthony Muslin M.D. | Chief Development Officer |
| Dr. Marc Schwabish Ph.D. | Chief Business Officer |
| John Diener | Senior Vice President of Antibody Engineering and Protein Sciences |
| Mary West M.S. | Senior Vice President of Clinical Development Operations |
Contact
| Address | 490 Arsenal Way, Suite 210, Watertown, Massachusetts 02472, United States |
| Phone | 339 666 3320 |
| Website | https://tectonictx.com |